Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Faes Farma S.A.

Home Clinical Trial Sponsors and OrganizationsFaes Farma S.A.

Faes Farma S.A.

Isidora Goyenechea 3120 8-A, Santiago, Chile

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

31

24 active

Approvals

109

Total approvals

Agencies

2

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

19

61.3%

Phase 3

1

3.2%

Phase 4

1

3.2%

Trial Status Distribution

Active, not recruiting

24

77.4%

Completed

3

9.7%

Recruiting

4

12.9%

Clinical Trials

Trials sponsored by this organization (31)

A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with active mild to moderate ulcerative colitis for the induction of remission.

Active, not recruiting

Apr 2024502 participants

A multicentre, open-label clinical trial to assess plasma levels and safety of bilastine in children from 2 to 5 years of age with seasonal and/or perennial allergic rhinoconjunctivitis or urticaria

Active, not recruiting

Oct 202139 participants

A clinical trial investigating the plasma concentration and the safety of bilastine in children between 2 and 5 years old treated for allergic rhinoconjunctivitis or urticaria

Active, not recruiting

Sep 202139 participants

A clinical trial investigating the plasma concentration and the safety of bilastine in children between 2 and 5 years old treated for allergic rhinoconjunctivitis or urticaria

Active, not recruiting

Sep 202139 participants

Clinical trial to evaluate if treatment with calcifediol (vitamin D analog) reduces the number of hospital admissions in patients with COVID-19.

Active, not recruiting

Jul 2021804 participants

Study to investigate the efficacy and safety of 3 different weekly dosages of calcifediol (versus placebo) in patients suffering from Vitamin D deficiency or insufficiency

Active, not recruiting

Nov 2020795 participants

Study to investigate the efficacy and safety of 3 different weekly dosages of calcifediol (versus placebo) in patients suffering from Vitamin D deficiency or insufficiency

Active, not recruiting

Oct 2020795 participants

Study to investigate the efficacy and safety of 3 different weekly dosages of calcifediol (versus placebo) in patients suffering from Vitamin D deficiency or insufficiency

Active, not recruiting

Sep 2020795 participants

Page 1 of 4

Approvals

Approvals by Agency

NPRA

National Pharmaceutical Regulatory Agency

2

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

107

Approvals

Recent Approvals

Bilaxten 20mg Orodispersible Tablets

MECOLZINE 500mg Gastro-resistant Tablet

ETOSUXIMIDA FAES 250 mg CAPSULAS DURAS

ZYLORIC 100 mg COMPRIMIDOS

SINERGINA 100 mg COMPRIMIDOS

ROBAXIN 500 mg COMPRIMIDOS

HEMORRANE 10 mg/g POMADA RECTAL

LASA CON CODEÍNA 6 mg/ml + 2 mg/ml + 0,4 mg/ml SOLUCIÓN ORAL

ROBAXISAL COMPUESTO 380 mg /300 mg COMPRIMIDOS

PANKREOFLAT 172 MG/80 MG COMPRIMIDOS RECUBIERTOS

News

No news articles found

On this page

Overview
Clinical Trials31
Approvals109
News

Back to Organizations